DaVita Inc. (0I7E.L)
USD 145.97
(-2.22%)
USD 145.97
(-2.22%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 8.05 Billion USD | -28.09% |
| 2022 | 11.19 Billion USD | -1.81% |
| 2021 | 11.4 Billion USD | 7.0% |
| 2020 | 10.65 Billion USD | -0.42% |
| 2019 | 10.7 Billion USD | 30.94% |
| 2018 | 8.17 Billion USD | -10.76% |
| 2017 | 9.15 Billion USD | 2.35% |
| 2016 | 8.94 Billion USD | -0.6% |
| 2015 | 9 Billion USD | 7.37% |
| 2014 | 8.38 Billion USD | 2.97% |
| 2013 | 8.14 Billion USD | -2.23% |
| 2012 | 8.32 Billion USD | 88.48% |
| 2011 | 4.41 Billion USD | 3.72% |
| 2010 | 4.25 Billion USD | 19.54% |
| 2009 | 3.56 Billion USD | -1.64% |
| 2008 | 3.62 Billion USD | -1.67% |
| 2007 | 3.68 Billion USD | -1.25% |
| 2006 | 3.73 Billion USD | -8.69% |
| 2005 | 4.08 Billion USD | 208.93% |
| 2004 | 1.32 Billion USD | 18.39% |
| 2003 | 1.11 Billion USD | -14.81% |
| 2002 | 1.31 Billion USD | 61.65% |
| 2001 | 811.19 Million USD | -16.72% |
| 2000 | 974 Million USD | 16999.82% |
| 1999 | 5.69 Million USD | -99.54% |
| 1998 | 1.22 Billion USD | 243.75% |
| 1997 | 356.6 Million USD | 247.56% |
| 1996 | 102.6 Million USD | 85.53% |
| 1995 | 55.3 Million USD | -37.02% |
| 1994 | 87.8 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 8.2 Billion USD | -8.81% |
| 2024 Q3 | 9.26 Billion USD | 12.83% |
| 2024 Q1 | 11.31 Billion USD | 11.79% |
| 2023 Q4 | 8.05 Billion USD | -24.24% |
| 2023 FY | 8.05 Billion USD | -28.09% |
| 2023 Q2 | 10.98 Billion USD | 1.01% |
| 2023 Q1 | 10.87 Billion USD | -2.89% |
| 2023 Q3 | 10.62 Billion USD | -3.24% |
| 2022 Q3 | 11.42 Billion USD | -2.11% |
| 2022 Q4 | 11.19 Billion USD | -2.01% |
| 2022 FY | 11.19 Billion USD | -1.81% |
| 2022 Q1 | 11.3 Billion USD | -0.81% |
| 2022 Q2 | 11.67 Billion USD | 3.2% |
| 2021 Q4 | 11.4 Billion USD | -0.75% |
| 2021 FY | 11.4 Billion USD | 7.0% |
| 2021 Q1 | 11.56 Billion USD | 8.57% |
| 2021 Q2 | 11.52 Billion USD | -0.38% |
| 2021 Q3 | 11.48 Billion USD | -0.33% |
| 2020 Q2 | 10.6 Billion USD | -5.12% |
| 2020 Q1 | 11.17 Billion USD | 4.44% |
| 2020 Q3 | 10.57 Billion USD | -0.26% |
| 2020 Q4 | 10.65 Billion USD | 0.75% |
| 2020 FY | 10.65 Billion USD | -0.42% |
| 2019 Q2 | 8.06 Billion USD | -4.11% |
| 2019 Q1 | 8.41 Billion USD | 2.94% |
| 2019 Q3 | 10.69 Billion USD | 32.6% |
| 2019 Q4 | 10.7 Billion USD | 0.04% |
| 2019 FY | 10.7 Billion USD | 30.94% |
| 2018 Q1 | 9.27 Billion USD | 1.33% |
| 2018 FY | 8.17 Billion USD | -10.76% |
| 2018 Q4 | 8.17 Billion USD | -3.17% |
| 2018 Q3 | 8.44 Billion USD | 3.24% |
| 2018 Q2 | 8.17 Billion USD | -11.9% |
| 2017 Q4 | 9.15 Billion USD | 2.8% |
| 2017 FY | 9.15 Billion USD | 2.35% |
| 2017 Q1 | 8.91 Billion USD | -0.32% |
| 2017 Q2 | 8.91 Billion USD | -0.09% |
| 2017 Q3 | 8.9 Billion USD | -0.02% |
| 2016 FY | 8.94 Billion USD | -0.6% |
| 2016 Q4 | 8.94 Billion USD | -0.28% |
| 2016 Q3 | 8.97 Billion USD | 0.16% |
| 2016 Q2 | 8.95 Billion USD | -0.25% |
| 2016 Q1 | 8.97 Billion USD | -0.24% |
| 2015 FY | 9 Billion USD | 7.37% |
| 2015 Q1 | 8.38 Billion USD | -0.04% |
| 2015 Q3 | 9.08 Billion USD | -0.21% |
| 2015 Q4 | 9 Billion USD | -0.89% |
| 2015 Q2 | 9.1 Billion USD | 8.6% |
| 2014 Q3 | 8.38 Billion USD | -0.12% |
| 2014 FY | 8.38 Billion USD | 2.97% |
| 2014 Q2 | 8.39 Billion USD | 3.95% |
| 2014 Q1 | 8.07 Billion USD | -0.86% |
| 2014 Q4 | 8.38 Billion USD | 0.03% |
| 2013 Q2 | 8.23 Billion USD | -0.52% |
| 2013 Q4 | 8.14 Billion USD | -0.49% |
| 2013 FY | 8.14 Billion USD | -2.23% |
| 2013 Q3 | 8.18 Billion USD | -0.64% |
| 2013 Q1 | 8.27 Billion USD | -0.59% |
| 2012 Q3 | 5.62 Billion USD | 27.95% |
| 2012 Q1 | 4.4 Billion USD | -0.36% |
| 2012 FY | 8.32 Billion USD | 88.48% |
| 2012 Q4 | 8.32 Billion USD | 48.14% |
| 2012 Q2 | 4.39 Billion USD | -0.2% |
| 2011 FY | 4.41 Billion USD | 3.72% |
| 2011 Q4 | 4.41 Billion USD | 0.0% |
| 2011 Q3 | 4.41 Billion USD | 4.91% |
| 2011 Q2 | 4.21 Billion USD | -0.74% |
| 2011 Q1 | 4.24 Billion USD | 0.2% |
| 2010 Q2 | 3.31 Billion USD | -6.32% |
| 2010 Q1 | 3.53 Billion USD | -0.67% |
| 2010 Q3 | 3.29 Billion USD | -0.68% |
| 2010 Q4 | 4.23 Billion USD | 28.58% |
| 2010 FY | 4.25 Billion USD | 19.54% |
| 2009 Q4 | 3.56 Billion USD | -0.7% |
| 2009 Q1 | 3.63 Billion USD | 0.34% |
| 2009 Q2 | 3.57 Billion USD | -1.53% |
| 2009 Q3 | 3.58 Billion USD | 0.24% |
| 2009 FY | 3.56 Billion USD | -1.64% |
| 2008 FY | 3.62 Billion USD | -1.67% |
| 2008 Q1 | 3.66 Billion USD | -0.38% |
| 2008 Q2 | 3.65 Billion USD | -0.35% |
| 2008 Q3 | 3.64 Billion USD | -0.38% |
| 2008 Q4 | 3.62 Billion USD | -0.57% |
| 2007 FY | 3.68 Billion USD | -1.25% |
| 2007 Q4 | 3.68 Billion USD | -0.32% |
| 2007 Q1 | 3.72 Billion USD | -0.24% |
| 2007 Q2 | 3.69 Billion USD | -0.62% |
| 2007 Q3 | 3.69 Billion USD | -0.08% |
| 2006 Q4 | 3.73 Billion USD | -2.3% |
| 2006 Q3 | 3.81 Billion USD | -3.07% |
| 2006 Q2 | 3.93 Billion USD | -2.48% |
| 2006 Q1 | 4.03 Billion USD | -1.13% |
| 2006 FY | 3.73 Billion USD | -8.69% |
| 2005 Q4 | 4.08 Billion USD | 200.25% |
| 2005 Q3 | 1.36 Billion USD | -0.05% |
| 2005 FY | 4.08 Billion USD | 208.93% |
| 2005 Q2 | 1.36 Billion USD | -0.05% |
| 2005 Q1 | 1.36 Billion USD | 2.99% |
| 2004 Q3 | 1.33 Billion USD | 21.97% |
| 2004 FY | 1.32 Billion USD | 18.39% |
| 2004 Q1 | 1.1 Billion USD | -1.05% |
| 2004 Q4 | 1.32 Billion USD | -0.92% |
| 2004 Q2 | 1.09 Billion USD | -1.0% |
| 2003 FY | 1.11 Billion USD | -14.81% |
| 2003 Q4 | 1.11 Billion USD | -12.23% |
| 2003 Q3 | 1.27 Billion USD | -9.72% |
| 2003 Q2 | 1.4 Billion USD | -0.77% |
| 2003 Q1 | 1.42 Billion USD | 8.34% |
| 2002 Q3 | 1.31 Billion USD | -0.18% |
| 2002 Q4 | 1.31 Billion USD | -0.2% |
| 2002 Q2 | 1.31 Billion USD | 64.79% |
| 2002 Q1 | 798.7 Million USD | -1.54% |
| 2002 FY | 1.31 Billion USD | 61.65% |
| 2001 Q4 | 811.19 Million USD | -0.34% |
| 2001 FY | 811.19 Million USD | -16.72% |
| 2001 Q3 | 813.97 Million USD | -12.97% |
| 2001 Q1 | 932.02 Million USD | -4.31% |
| 2001 Q2 | 935.24 Million USD | 0.35% |
| 2000 Q1 | 5.02 Million USD | -11.75% |
| 2000 Q3 | 1.03 Billion USD | -13.0% |
| 2000 Q4 | 974 Million USD | -5.77% |
| 2000 Q2 | 1.18 Billion USD | 23535.05% |
| 2000 FY | 974 Million USD | 16999.82% |
| 1999 Q1 | 1.32 Billion USD | 8.08% |
| 1999 Q4 | 5.69 Million USD | -99.6% |
| 1999 Q3 | 1.43 Billion USD | 1.78% |
| 1999 FY | 5.69 Million USD | -99.54% |
| 1999 Q2 | 1.4 Billion USD | 6.36% |
| 1998 Q4 | 1.22 Billion USD | 7.47% |
| 1998 Q1 | 931.6 Million USD | 161.25% |
| 1998 Q3 | 1.14 Billion USD | 9.15% |
| 1998 FY | 1.22 Billion USD | 243.75% |
| 1998 Q2 | 1.04 Billion USD | 12.17% |
| 1997 Q1 | 102.5 Million USD | -0.1% |
| 1997 Q2 | 192.1 Million USD | 87.41% |
| 1997 Q3 | 253.9 Million USD | 32.17% |
| 1997 Q4 | 356.6 Million USD | 40.45% |
| 1997 FY | 356.6 Million USD | 247.56% |
| 1996 FY | 102.6 Million USD | 85.53% |
| 1996 Q4 | 102.6 Million USD | 29.87% |
| 1996 Q2 | 59.1 Million USD | -45.18% |
| 1996 Q1 | 107.8 Million USD | 96.0% |
| 1996 Q3 | 79 Million USD | 33.67% |
| 1995 Q2 | 87.8 Million USD | 0.0% |
| 1995 Q3 | 101.2 Million USD | 15.26% |
| 1995 FY | 55.3 Million USD | -37.02% |
| 1995 Q4 | 55 Million USD | -45.65% |
| 1994 FY | 87.8 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -392835.725% |
| Accuray Incorporated | 164.4 Million USD | -4797.356% |
| Align Technology, Inc. | 96.96 Million USD | -8203.0% |
| Elevance Health Inc. | 23.24 Billion USD | 65.365% |
| AxoGen, Inc. | 46.6 Million USD | -17176.255% |
| Boston Scientific Corporation | 8.56 Billion USD | 6.009% |
| CVS Health Corporation | 74.67 Billion USD | 89.218% |
| Cardinal Health, Inc. | 4.58 Billion USD | -75.676% |
| Centene Corporation | 17.69 Billion USD | 54.51% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 78.019% |
| Hologic, Inc. | 2.49 Billion USD | -222.424% |
| Humana Inc. | 10.21 Billion USD | 21.167% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -1192.579% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | -98.566% |
| Masimo Corporation | 871.7 Million USD | -823.627% |
| McKesson Corporation | 5.45 Billion USD | -47.702% |
| Patterson Companies, Inc. | 328.91 Million USD | -2347.852% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | -82.568% |
| ResMed Inc. | 697.31 Million USD | -1054.611% |
| Henry Schein, Inc. | 1.93 Billion USD | -316.516% |
| Teladoc Health, Inc. | 1.58 Billion USD | -409.082% |
| Universal Health Services, Inc. | 4.71 Billion USD | -70.717% |
| Veeva Systems Inc. | 46.44 Million USD | -17236.519% |
| Baxter International Inc. | 11.06 Billion USD | 27.23% |
| Becton, Dickinson and Company | 14.73 Billion USD | 45.371% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 9906.642% |
| Danaher Corporation | 17.66 Billion USD | 54.412% |
| Stryker Corporation | 10.9 Billion USD | 26.142% |
| Medtronic plc | 23.87 Billion USD | 66.28% |